-
1
-
-
0141727870
-
Safety and utilization of blood components as therapeutic delivery systems
-
Adams T, Alanazi F, Lu DR. 2003. Safety and utilization of blood components as therapeutic delivery systems. Curr Pharm Biotechnol 4(5):275-282.
-
(2003)
Curr Pharm Biotechnol
, vol.4
, Issue.5
, pp. 275-282
-
-
Adams, T.1
Alanazi, F.2
Lu, D.R.3
-
2
-
-
84877948067
-
Red blood cell-encapsulated l-asparaginase: Potential Therapy of patients with asparagine synthetase deficient acute myeloid leukemia
-
Agrawal V, Hee Woo J, Borthakur G, Kantarjian HE, Frankel A. 2013. Red blood cell-encapsulated l-asparaginase: Potential Therapy of patients with asparagine synthetase deficient acute myeloid leukemia. Protein Pept Lett 20(4):392-402.
-
(2013)
Protein Pept Lett
, vol.20
, Issue.4
, pp. 392-402
-
-
Agrawal, V.1
Hee Woo, J.2
Borthakur, G.3
Kantarjian, H.E.4
Frankel, A.5
-
3
-
-
79960405094
-
Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study
-
Alanazi F, Harisa G-D, Maqboul A, Abdel-Hamid M, Neau S, Alsarra I. 2011. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study. Arch Pharm Res 34(4):563-571.
-
(2011)
Arch Pharm Res
, vol.34
, Issue.4
, pp. 563-571
-
-
Alanazi, F.1
Harisa, G.-D.2
Maqboul, A.3
Abdel-Hamid, M.4
Neau, S.5
Alsarra, I.6
-
4
-
-
0036527585
-
Molecular mechanisms of lymphangiogenesis in health and disease
-
Alitalo K, Carmeliet P. 2002. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1(3):219-227.
-
(2002)
Cancer Cell
, vol.1
, Issue.3
, pp. 219-227
-
-
Alitalo, K.1
Carmeliet, P.2
-
5
-
-
79953858598
-
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
-
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood M. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341-345.
-
(2011)
Nat Biotechnol
, vol.29
, Issue.4
, pp. 341-345
-
-
Alvarez-Erviti, L.1
Seow, Y.2
Yin, H.3
Betts, C.4
Lakhal, S.5
Wood, M.6
-
6
-
-
0036705298
-
P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury
-
Amersi F, Farmer DG, Shaw GD, Kato H, Coito AJ, Kaldas F, Zhao D, Lassman CR, Melinek J, Ma J, Volk HD, Kupiec-Weglinski JW, Busuttil RW. 2002. P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury. Am J Transplant 2(7):600-608.
-
(2002)
Am J Transplant
, vol.2
, Issue.7
, pp. 600-608
-
-
Amersi, F.1
Farmer, D.G.2
Shaw, G.D.3
Kato, H.4
Coito, A.J.5
Kaldas, F.6
Zhao, D.7
Lassman, C.R.8
Melinek, J.9
Ma, J.10
Volk, H.D.11
Kupiec-Weglinski, J.W.12
Busuttil, R.W.13
-
7
-
-
33745508741
-
Perspective-FcRn transports albumin: Relevance to immunology and medicine
-
Anderson C, Chaudhury C, Kim J, Bronson C, Wani M, Mohanty S. 2006. Perspective-FcRn transports albumin: Relevance to immunology and medicine. Trends Immunol 27(7):343-348.
-
(2006)
Trends Immunol
, vol.27
, Issue.7
, pp. 343-348
-
-
Anderson, C.1
Chaudhury, C.2
Kim, J.3
Bronson, C.4
Wani, M.5
Mohanty, S.6
-
8
-
-
0026652116
-
The biological chemistry of folate receptors
-
Antony AC. 1992. The biological chemistry of folate receptors. Blood 79(11):2807-2820.
-
(1992)
Blood
, vol.79
, Issue.11
, pp. 2807-2820
-
-
Antony, A.C.1
-
9
-
-
4344667831
-
A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis
-
Baggio L, Huang Q, Brown T, Drucker D. 2004. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes 53(9):2492-2500.
-
(2004)
Diabetes
, vol.53
, Issue.9
, pp. 2492-2500
-
-
Baggio, L.1
Huang, Q.2
Brown, T.3
Drucker, D.4
-
10
-
-
85007042722
-
Fusion proteins containing n-terminal fragments of human serum albumin
-
Ballance DJ. 1993. Fusion proteins containing n-terminal fragments of human serum albumin. Google Patents.
-
(1993)
Google Patents
-
-
Ballance, D.J.1
-
12
-
-
0345357073
-
Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery
-
Bellocq NC, Pun SH, Jensen GS, Davis ME. 2003. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 14(6):1122-1132.
-
(2003)
Bioconjug Chem
, vol.14
, Issue.6
, pp. 1122-1132
-
-
Bellocq, N.C.1
Pun, S.H.2
Jensen, G.S.3
Davis, M.E.4
-
13
-
-
0017752970
-
Enzyme replacement therapy in Gaucher's disease: Preliminary clinical trial of a new enzyme preparation
-
Beutler E, Dale G, Guinto D, Kuhl W. 1977. Enzyme replacement therapy in Gaucher's disease: Preliminary clinical trial of a new enzyme preparation. Proc Natl Acad Sci USA 74(10):4620-4623.
-
(1977)
Proc Natl Acad Sci USA
, vol.74
, Issue.10
, pp. 4620-4623
-
-
Beutler, E.1
Dale, G.2
Guinto, D.3
Kuhl, W.4
-
14
-
-
0031855765
-
Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil
-
Beyer U, Roth T, Schumacher P, Maier G, Unold A, Frahm A, Fiebig H, Unger C, Kratz F. 1998. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil. J Med Chem 41(15):2701-2708.
-
(1998)
J Med Chem
, vol.41
, Issue.15
, pp. 2701-2708
-
-
Beyer, U.1
Roth, T.2
Schumacher, P.3
Maier, G.4
Unold, A.5
Frahm, A.6
Fiebig, H.7
Unger, C.8
Kratz, F.9
-
15
-
-
67650388093
-
Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis
-
Bracewell C, Isaacs J, Emery P, Ng W. 2009. Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis. Expert Opin Biol Ther 9(7):909-919.
-
(2009)
Expert Opin Biol Ther
, vol.9
, Issue.7
, pp. 909-919
-
-
Bracewell, C.1
Isaacs, J.2
Emery, P.3
Ng, W.4
-
17
-
-
70349835152
-
Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes
-
Briones E, Colino CI, Millán CG, Lanao JM. 2009. Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes. Eur J Pharm Sci 38(4):320-324.
-
(2009)
Eur J Pharm Sci
, vol.38
, Issue.4
, pp. 320-324
-
-
Briones, E.1
Colino, C.I.2
Millán, C.G.3
Lanao, J.M.4
-
18
-
-
0004078454
-
-
San Diego, CA, United States: Academic Press
-
Brody T. 1999. Nutritional Biochemistry. San Diego, CA, United States: Academic Press. p 332-345.
-
(1999)
Nutritional Biochemistry
, pp. 332-345
-
-
Brody, T.1
-
19
-
-
77951235242
-
Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease
-
Brynskikh A, Zhao Y, Mosley R, Li S, Boska M, Klyachko N, Kabanov A, Gendelman H, Batrakova E. 2010. Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine (London, England) 5(3):379-396.
-
(2010)
Nanomedicine (London, England)
, vol.5
, Issue.3
, pp. 379-396
-
-
Brynskikh, A.1
Zhao, Y.2
Mosley, R.3
Li, S.4
Boska, M.5
Klyachko, N.6
Kabanov, A.7
Gendelman, H.8
Batrakova, E.9
-
21
-
-
0035827185
-
Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin
-
Candiani C, Tommasi M, Fracasso G, Lorenzetti I, Adami A, Benoni G, Tridente G, Colombatti M. 2001. Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin. Life Sci 69(3):335-346.
-
(2001)
Life Sci
, vol.69
, Issue.3
, pp. 335-346
-
-
Candiani, C.1
Tommasi, M.2
Fracasso, G.3
Lorenzetti, I.4
Adami, A.5
Benoni, G.6
Tridente, G.7
Colombatti, M.8
-
22
-
-
0024575860
-
Designing CD4 immunoadhesins for AIDS therapy
-
Capon D, Chamow S, Mordenti J, Marsters S, Gregory T, Mitsuya H, Byrn R, Lucas C, Wurm F, Groopman J. 1989. Designing CD4 immunoadhesins for AIDS therapy. Nature 337(6207):525-531.
-
(1989)
Nature
, vol.337
, Issue.6207
, pp. 525-531
-
-
Capon, D.1
Chamow, S.2
Mordenti, J.3
Marsters, S.4
Gregory, T.5
Mitsuya, H.6
Byrn, R.7
Lucas, C.8
Wurm, F.9
Groopman, J.10
-
23
-
-
34347400391
-
Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation
-
Chambers E, Mitragotri S. 2007. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation. Exp Biol Med 232(7):958-966.
-
(2007)
Exp Biol Med
, vol.232
, Issue.7
, pp. 958-966
-
-
Chambers, E.1
Mitragotri, S.2
-
24
-
-
9944261933
-
Insulin detemir: A review of its use in the management of type 1 and 2 diabetes mellitus
-
Chapman T, Perry C. 2004. Insulin detemir: A review of its use in the management of type 1 and 2 diabetes mellitus. Drugs 64(22):2577-2595.
-
(2004)
Drugs
, vol.64
, Issue.22
, pp. 2577-2595
-
-
Chapman, T.1
Perry, C.2
-
25
-
-
0037415556
-
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan
-
Chaudhury C, Mehnaz S, Robinson J, Hayton W, Pearl D, Roopenian D, Anderson C. 2003. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197(3):315-322.
-
(2003)
J Exp Med
, vol.197
, Issue.3
, pp. 315-322
-
-
Chaudhury, C.1
Mehnaz, S.2
Robinson, J.3
Hayton, W.4
Pearl, D.5
Roopenian, D.6
Anderson, C.7
-
26
-
-
84882818980
-
Structural basis for molecular recognition of folic acid by folate receptors
-
Chen C, Ke J, Zhou XE, Yi W, Brunzelle JS, Li J, Yong E-L, Xu HE, Melcher K. 2013. Structural basis for molecular recognition of folic acid by folate receptors. Nature 500(7463):486-489.
-
(2013)
Nature
, vol.500
, Issue.7463
, pp. 486-489
-
-
Chen, C.1
Ke, J.2
Zhou, X.E.3
Yi, W.4
Brunzelle, J.S.5
Li, J.6
Yong, E.-L.7
Xu, H.E.8
Melcher, K.9
-
27
-
-
34248597761
-
Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo
-
Chen J, Corbin IR, Li H, Cao W, Glickson JD, Zheng G. 2007. Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. J Am Chem Soc 129(18):5798-5799.
-
(2007)
J Am Chem Soc
, vol.129
, Issue.18
, pp. 5798-5799
-
-
Chen, J.1
Corbin, I.R.2
Li, H.3
Cao, W.4
Glickson, J.D.5
Zheng, G.6
-
28
-
-
85018501567
-
Advanced drug delivery in cancer therapy
-
In: Ashim Mitra CHL, Cheng K. Hoboken, New Jersey: JohnWiley & Sons.
-
Cheng W, Tai K. 2013. Advanced drug delivery in cancer therapy. In: Ashim Mitra CHL, Cheng K. Advanced drug delivery. Hoboken, New Jersey: JohnWiley & Sons.
-
(2013)
Advanced drug delivery
-
-
Cheng, W.1
Tai, K.2
-
29
-
-
84892158748
-
Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial
-
Chessa L, Leuzzi V, Plebani A, Soresina A, Micheli R, D'Agnano D, Venturi T, Molinaro A, Fazzi E, Marini M, Ferremi Leali P, Quinti I, Cavaliere FM, Girelli G, Pietrogrande MC, Finocchi A, Tabolli S, Abeni D, Magnani M. 2014. Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial. Orphanet J Rare Dis 9(1):1750-1172.
-
(2014)
Orphanet J Rare Dis
, vol.9
, Issue.1
, pp. 1172-1750
-
-
Chessa, L.1
Leuzzi, V.2
Plebani, A.3
Soresina, A.4
Micheli, R.5
D'Agnano, D.6
Venturi, T.7
Molinaro, A.8
Fazzi, E.9
Marini, M.10
Ferremi Leali, P.11
Quinti, I.12
Cavaliere, F.M.13
Girelli, G.14
Pietrogrande, M.C.15
Finocchi, A.16
Tabolli, S.17
Abeni, D.18
Magnani, M.19
-
30
-
-
38049131877
-
A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors
-
Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP, Bashir R, Halas NJ, Clare SE. 2007. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 7(12):3759-3765.
-
(2007)
Nano Lett
, vol.7
, Issue.12
, pp. 3759-3765
-
-
Choi, M.R.1
Stanton-Maxey, K.J.2
Stanley, J.K.3
Levin, C.S.4
Bardhan, R.5
Akin, D.6
Badve, S.7
Sturgis, J.8
Robinson, J.P.9
Bashir, R.10
Halas, N.J.11
Clare, S.E.12
-
31
-
-
84881582632
-
Ligand-Coupled Lipoprotein for Ovarian Cancer-Specific Drug Delivery
-
In: Malek A, Tchernitsa O. Humana Press
-
Corbin I. 2013. Ligand-Coupled Lipoprotein for Ovarian Cancer-Specific Drug Delivery. In: Malek A, Tchernitsa O. Ovarian Cancer. Humana Press. p 467-480.
-
(2013)
Ovarian Cancer
, pp. 467-480
-
-
Corbin, I.1
-
32
-
-
0036553910
-
Erythrocytes deliver Tat to interferon-γ-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro
-
Corinti S, Chiarantini L, Dominici S, Laguardia ME, Magnani M, Girolomoni G. 2002. Erythrocytes deliver Tat to interferon-γ-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro. J Leukoc Biol 71(4):652-658.
-
(2002)
J Leukoc Biol
, vol.71
, Issue.4
, pp. 652-658
-
-
Corinti, S.1
Chiarantini, L.2
Dominici, S.3
Laguardia, M.E.4
Magnani, M.5
Girolomoni, G.6
-
33
-
-
84902714169
-
-
San Diego, CA, United States: Elsevier.
-
Dasgupta A, Wahed A. 2014. Clinical Chemistry, Immunology and Laboratory Quality Control: A Comprehensive Review for Board Preparation, Certification and Clinical Practice. San Diego, CA, United States: Elsevier. p 85-89.
-
(2014)
Clinical Chemistry, Immunology and Laboratory Quality Control: A Comprehensive Review for Board Preparation, Certification and Clinical Practice
, pp. 85-89
-
-
Dasgupta, A.1
Wahed, A.2
-
34
-
-
33644753906
-
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel
-
Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon-Shiong P. 2006. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 12(4):1317-1324.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.4
, pp. 1317-1324
-
-
Desai, N.1
Trieu, V.2
Yao, Z.3
Louie, L.4
Ci, S.5
Yang, A.6
Tao, C.7
De, T.8
Beals, B.9
Dykes, D.10
Noker, P.11
Yao, R.12
Labao, E.13
Hawkins, M.14
Soon-Shiong, P.15
-
35
-
-
24944506410
-
Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy
-
Dierling A, Cui Z. 2005. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. Int J Pharm 303(1-2):143-152.
-
(2005)
Int J Pharm
, vol.303
, Issue.1-2
, pp. 143-152
-
-
Dierling, A.1
Cui, Z.2
-
36
-
-
84862847986
-
Nanosized multifunctional polyplexes for receptor-mediated SiRNA delivery
-
Dohmen C, Edinger D, Fröhlich T, Schreiner L, Lächelt U, Troiber C, Rädler J, Hadwiger P, Vornlocher H-P, Wagner E. 2012a. Nanosized multifunctional polyplexes for receptor-mediated SiRNA delivery. ACS Nano 6(6):5198-5208.
-
(2012)
ACS Nano
, vol.6
, Issue.6
, pp. 5198-5208
-
-
Dohmen, C.1
Edinger, D.2
Fröhlich, T.3
Schreiner, L.4
Lächelt, U.5
Troiber, C.6
Rädler, J.7
Hadwiger, P.8
Vornlocher, H.-P.9
Wagner, E.10
-
37
-
-
84862326949
-
Defined folate-PEG-siRNA conjugates for receptorspecific gene silencing
-
Dohmen C, Fröhlich T, Lächelt U, Röhl I, Vornlocher H-P, Hadwiger P, Wagner E. 2012b. Defined folate-PEG-siRNA conjugates for receptorspecific gene silencing. Mol Ther Nucleic Acids 1(1):e7.
-
(2012)
Mol Ther Nucleic Acids
, vol.1
, Issue.1
-
-
Dohmen, C.1
Fröhlich, T.2
Lächelt, U.3
Röhl, I.4
Vornlocher, H.-P.5
Hadwiger, P.6
Wagner, E.7
-
38
-
-
79953031661
-
Cell-based drug delivery devices using phagocytosis-resistant backpacks
-
Doshi N, Swiston A, Gilbert J, Alcaraz M, Cohen R, Rubner M, Mitragotri S. 2011. Cell-based drug delivery devices using phagocytosis-resistant backpacks. Adv Mater 23(12):9.
-
(2011)
Adv Mater
, vol.23
, Issue.12
, pp. 9
-
-
Doshi, N.1
Swiston, A.2
Gilbert, J.3
Alcaraz, M.4
Cohen, R.5
Rubner, M.6
Mitragotri, S.7
-
39
-
-
70350187071
-
Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system
-
Dosio F, Arpicco S, Stella B, Brusa P, Cattel L. 2009. Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. Int J Pharm 382(1-2):117-123.
-
(2009)
Int J Pharm
, vol.382
, Issue.1-2
, pp. 117-123
-
-
Dosio, F.1
Arpicco, S.2
Stella, B.3
Brusa, P.4
Cattel, L.5
-
40
-
-
79952746215
-
EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers
-
Dosio F, Milla P, Cattel L. 2010. EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers. Curr Opin Investig Drugs 11(12):1424-1433.
-
(2010)
Curr Opin Investig Drugs
, vol.11
, Issue.12
, pp. 1424-1433
-
-
Dosio, F.1
Milla, P.2
Cattel, L.3
-
41
-
-
33750611615
-
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
-
Dou H, Destache CJ, Morehead JR, Mosley RL, Boska MD, Kingsley J, Gorantla S, Poluektova L, Nelson JA, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman H. 2006. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 108(8):2827-2835.
-
(2006)
Blood
, vol.108
, Issue.8
, pp. 2827-2835
-
-
Dou, H.1
Destache, C.J.2
Morehead, J.R.3
Mosley, R.L.4
Boska, M.D.5
Kingsley, J.6
Gorantla, S.7
Poluektova, L.8
Nelson, J.A.9
Chaubal, M.10
Werling, J.11
Kipp, J.12
Rabinow, B.13
Gendelman, H.14
-
42
-
-
68949102075
-
Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS
-
Dou H, Grotepas C, McMillan J, Destache C, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman H. 2009. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183(1):661-669.
-
(2009)
J Immunol
, vol.183
, Issue.1
, pp. 661-669
-
-
Dou, H.1
Grotepas, C.2
McMillan, J.3
Destache, C.4
Chaubal, M.5
Werling, J.6
Kipp, J.7
Rabinow, B.8
Gendelman, H.9
-
43
-
-
78650408680
-
RGD modified albumin nanospheres for tumour vasculature targeting
-
Dubey P, Singodia D, Verma R, Vyas S. 2011. RGD modified albumin nanospheres for tumour vasculature targeting. J Pharm Pharmacol 63(1):33-40.
-
(2011)
J Pharm Pharmacol
, vol.63
, Issue.1
, pp. 33-40
-
-
Dubey, P.1
Singodia, D.2
Verma, R.3
Vyas, S.4
-
44
-
-
0033515598
-
Expression and characterization of a DNase I-Fc fusion enzyme
-
Dwyer M, Huang A, Pan C, Lazarus R. 1999. Expression and characterization of a DNase I-Fc fusion enzyme. J Biol Chem 274(14):9738-9743.
-
(1999)
J Biol Chem
, vol.274
, Issue.14
, pp. 9738-9743
-
-
Dwyer, M.1
Huang, A.2
Pan, C.3
Lazarus, R.4
-
45
-
-
0037231664
-
Cytokine traps: multicomponent, high-affinity blockers of cytokine action
-
Economides A, Carpenter L, Rudge J, Wong V, Koehler-Stec E, Hartnett C, Pyles E, Xu X, Daly T, Young M, Fandl J, Lee F, Carver S, McNay J, Bailey K, Ramakanth S, Hutabarat R, Huang T, Radziejewski C, Yancopoulos G, Stahl N. 2003. Cytokine traps: multicomponent, high-affinity blockers of cytokine action. Nat Med 9(1):47-52.
-
(2003)
Nat Med
, vol.9
, Issue.1
, pp. 47-52
-
-
Economides, A.1
Carpenter, L.2
Rudge, J.3
Wong, V.4
Koehler-Stec, E.5
Hartnett, C.6
Pyles, E.7
Xu, X.8
Daly, T.9
Young, M.10
Fandl, J.11
Lee, F.12
Carver, S.13
McNay, J.14
Bailey, K.15
Ramakanth, S.16
Hutabarat, R.17
Huang, T.18
Radziejewski, C.19
Yancopoulos, G.20
Stahl, N.21
more..
-
46
-
-
0022553643
-
In vivo clearance of antibody-sensitized human drug carrier erythrocytes
-
Eichler HG, Gasic S, Bauer K, Korn A, Bacher S. 1986. In vivo clearance of antibody-sensitized human drug carrier erythrocytes. Clin Pharmacol Ther 40(3):300-303.
-
(1986)
Clin Pharmacol Ther
, vol.40
, Issue.3
, pp. 300-303
-
-
Eichler, H.G.1
Gasic, S.2
Bauer, K.3
Korn, A.4
Bacher, S.5
-
47
-
-
68249129865
-
Docetaxel-albumin conjugates: Preparation, in vitro evaluation and biodistribution studies
-
Esmaeili F, Dinarvand R, Ghahremani M, Amini M, Rouhani H, Sepehri N, Ostad S, Atyabi F. 2009. Docetaxel-albumin conjugates: Preparation, in vitro evaluation and biodistribution studies. J Pharm Sci 98(8):2718-2730.
-
(2009)
J Pharm Sci
, vol.98
, Issue.8
, pp. 2718-2730
-
-
Esmaeili, F.1
Dinarvand, R.2
Ghahremani, M.3
Amini, M.4
Rouhani, H.5
Sepehri, N.6
Ostad, S.7
Atyabi, F.8
-
48
-
-
84861526023
-
Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163
-
Etzerodt A, Maniecki MB, Graversen JH, Møller HJ, Torchilin VP, Moestrup SK. 2012. Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. J Control Release 160(1):72-80.
-
(2012)
J Control Release
, vol.160
, Issue.1
, pp. 72-80
-
-
Etzerodt, A.1
Maniecki, M.B.2
Graversen, J.H.3
Møller, H.J.4
Torchilin, V.P.5
Moestrup, S.K.6
-
49
-
-
19944433993
-
CD62 blockade with P-selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemiareperfusion injury after rat intestinal transplantation
-
Farmer D, Shen X, Amersi F, Anselmo D, Ma J, Ke B, Gao F, Dry S, Fernandez S, Shaw G, McDiarmid S, Busuttil R, Kupiec-Weglinski J. 2005. CD62 blockade with P-selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemiareperfusion injury after rat intestinal transplantation. Transplantation 79(1):44-51.
-
(2005)
Transplantation
, vol.79
, Issue.1
, pp. 44-51
-
-
Farmer, D.1
Shen, X.2
Amersi, F.3
Anselmo, D.4
Ma, J.5
Ke, B.6
Gao, F.7
Dry, S.8
Fernandez, S.9
Shaw, G.10
McDiarmid, S.11
Busuttil, R.12
Kupiec-Weglinski, J.13
-
50
-
-
0027022186
-
Targeting of tumor cells by low density lipoproteins: Principle and use of ellipticin derivatives
-
Favre G. 1992. Targeting of tumor cells by low density lipoproteins: Principle and use of ellipticin derivatives. C R Seances Soc Biol Fil 186(1-2):73-87.
-
(1992)
C R Seances Soc Biol Fil
, vol.186
, Issue.1-2
, pp. 73-87
-
-
Favre, G.1
-
51
-
-
47949115836
-
Targeted drug delivery by in vivo coupling to endogenous albumin: An albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis
-
Fiehn C, Kratz F, Sass G, Müller-Ladner U, Neumann E. 2008. Targeted drug delivery by in vivo coupling to endogenous albumin: An albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann Rheum Dis 67(8):1188-1191.
-
(2008)
Ann Rheum Dis
, vol.67
, Issue.8
, pp. 1188-1191
-
-
Fiehn, C.1
Kratz, F.2
Sass, G.3
Müller-Ladner, U.4
Neumann, E.5
-
52
-
-
0028386492
-
Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells
-
Firestone RA. 1994. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem 5(2):105-113.
-
(1994)
Bioconjug Chem
, vol.5
, Issue.2
, pp. 105-113
-
-
Firestone, R.A.1
-
53
-
-
14744306199
-
Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts
-
Fleer R, Yeh P, Amellal N, Maury I, Fournier A, Bacchetta F, Baduel P, Jung G, L'Hôte H, Becquart J. 1991. Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts. Bio/technology (Nature Publishing Company) 9(10):968-975.
-
(1991)
Bio/technology (Nature Publishing Company)
, vol.9
, Issue.10
, pp. 968-975
-
-
Fleer, R.1
Yeh, P.2
Amellal, N.3
Maury, I.4
Fournier, A.5
Bacchetta, F.6
Baduel, P.7
Jung, G.8
L'Hôte, H.9
Becquart, J.10
-
54
-
-
10644250277
-
SPARC and tumor growth: Where the seed meets the soil
-
Framson P, Sage E. 2004. SPARC and tumor growth: Where the seed meets the soil? J Cell Biochem 92(4):679-690.
-
(2004)
J Cell Biochem
, vol.92
, Issue.4
, pp. 679-690
-
-
Framson, P.1
Sage, E.2
-
55
-
-
0036888324
-
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model
-
Fraternale A, Casabianca A, Orlandi C, Cerasi A, Chiarantini L, Brandi G, Magnani M. 2002. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. Antiviral Res 56(3):263-272.
-
(2002)
Antiviral Res
, vol.56
, Issue.3
, pp. 263-272
-
-
Fraternale, A.1
Casabianca, A.2
Orlandi, C.3
Cerasi, A.4
Chiarantini, L.5
Brandi, G.6
Magnani, M.7
-
56
-
-
70350776969
-
Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery
-
Fu Q, Sun J, Zhang W, Sui X, Yan Z, He Z. 2009. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Pat Anticancer Drug Discov 4(3):262-272.
-
(2009)
Recent Pat Anticancer Drug Discov
, vol.4
, Issue.3
, pp. 262-272
-
-
Fu, Q.1
Sun, J.2
Zhang, W.3
Sui, X.4
Yan, Z.5
He, Z.6
-
57
-
-
14344252453
-
Blood clearance and activity of erythrocyte-coupled fibrinolytics
-
Ganguly K, Krasik T, Medinilla S, Bdeir K, Cines DB, Muzykantov VR, Murciano JC. 2005. Blood clearance and activity of erythrocyte-coupled fibrinolytics. J Pharmacol Exp Ther 312(3):1106-1113.
-
(2005)
J Pharmacol Exp Ther
, vol.312
, Issue.3
, pp. 1106-1113
-
-
Ganguly, K.1
Krasik, T.2
Medinilla, S.3
Bdeir, K.4
Cines, D.B.5
Muzykantov, V.R.6
Murciano, J.C.7
-
58
-
-
33745458519
-
Albumin-bound paclitaxel: A next-generation taxane
-
Gradishar W. 2006. Albumin-bound paclitaxel: A next-generation taxane. Expert Opin Pharmacother 7(8):1041-1053.
-
(2006)
Expert Opin Pharmacother
, vol.7
, Issue.8
, pp. 1041-1053
-
-
Gradishar, W.1
-
59
-
-
34447301770
-
Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain
-
Gupta Y, Jain A, Jain SK. 2007. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol 59(7):935-940.
-
(2007)
J Pharm Pharmacol
, vol.59
, Issue.7
, pp. 935-940
-
-
Gupta, Y.1
Jain, A.2
Jain, S.K.3
-
60
-
-
0035196771
-
In vitro characterization of human intact erythrocytes loaded by enalaprilat
-
Hamidi M, Tajerzadeh H, Dehpour A-R, Rouini M-R, Ejtemaee-Mehr S. 2001. In vitro characterization of human intact erythrocytes loaded by enalaprilat. Drug Deliv 8(4):223-230.
-
(2001)
Drug Deliv
, vol.8
, Issue.4
, pp. 223-230
-
-
Hamidi, M.1
Tajerzadeh, H.2
Dehpour, A.-R.3
Rouini, M.-R.4
Ejtemaee-Mehr, S.5
-
61
-
-
0037390497
-
Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system
-
Hammel M, Laggner P, Prassl R. 2003. Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system. Chem Phys Lipids 123(2):193-207.
-
(2003)
Chem Phys Lipids
, vol.123
, Issue.2
, pp. 193-207
-
-
Hammel, M.1
Laggner, P.2
Prassl, R.3
-
62
-
-
0032822827
-
Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier
-
Han J-H, Oh Y-K, Kim D-S, Kim C-K. 1999. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier. Int J Pharm 188(1):39-47.
-
(1999)
Int J Pharm
, vol.188
, Issue.1
, pp. 39-47
-
-
Han, J.-H.1
Oh, Y.-K.2
Kim, D.-S.3
Kim, C.-K.4
-
63
-
-
84876436797
-
Specific transfection of inflamed brain by macrophages: A new therapeutic strategy for neurodegenerative diseases
-
Haney M, Zhao Y, Harrison E, Mahajan V, Ahmed S, He Z, Suresh P, Hingtgen S, Klyachko N, Mosley R, Gendelman H, Kabanov A, Batrakova E. 2013. Specific transfection of inflamed brain by macrophages: A new therapeutic strategy for neurodegenerative diseases. PloS ONE 8(4):e61852.
-
(2013)
PloS ONE
, vol.8
, Issue.4
-
-
Haney, M.1
Zhao, Y.2
Harrison, E.3
Mahajan, V.4
Ahmed, S.5
He, Z.6
Suresh, P.7
Hingtgen, S.8
Klyachko, N.9
Mosley, R.10
Gendelman, H.11
Kabanov, A.12
Batrakova, E.13
-
64
-
-
33748294199
-
Synthesis and activity of a folate peptide camptothecin prodrug
-
Henne WA, Doorneweerd DD, Hilgenbrink AR, Kularatne SA, Low PS. 2006. Synthesis and activity of a folate peptide camptothecin prodrug. Bioorg Med Chem Lett 16(20):5350-5355.
-
(2006)
Bioorg Med Chem Lett
, vol.16
, Issue.20
, pp. 5350-5355
-
-
Henne, W.A.1
Doorneweerd, D.D.2
Hilgenbrink, A.R.3
Kularatne, S.A.4
Low, P.S.5
-
65
-
-
33745829014
-
The leak stops here: Platelets as delivery vehicles for coagulation factors
-
High K. 2006. The leak stops here: Platelets as delivery vehicles for coagulation factors. J Clin Invest 116(7):1840-1842.
-
(2006)
J Clin Invest
, vol.116
, Issue.7
, pp. 1840-1842
-
-
High, K.1
-
66
-
-
44949160947
-
Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake
-
Hodson L, Skeaff C, Fielding B. 2008. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47(5):348-380.
-
(2008)
Prog Lipid Res
, vol.47
, Issue.5
, pp. 348-380
-
-
Hodson, L.1
Skeaff, C.2
Fielding, B.3
-
67
-
-
49449094179
-
Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
-
Hoffman H, Throne M, Amar N, Sebai M, Kivitz A, Kavanaugh A, Weinstein S, Belomestnov P, Yancopoulos G, Stahl N, Mellis S. 2008. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies. Arthritis Rheum 58(8):2443-2452.
-
(2008)
Arthritis Rheum
, vol.58
, Issue.8
, pp. 2443-2452
-
-
Hoffman, H.1
Throne, M.2
Amar, N.3
Sebai, M.4
Kivitz, A.5
Kavanaugh, A.6
Weinstein, S.7
Belomestnov, P.8
Yancopoulos, G.9
Stahl, N.10
Mellis, S.11
-
68
-
-
77951188983
-
Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery
-
Holden CA, Yuan Q, Yeudall WA, Lebman DA, Yan H. 2010. Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery. Int J Nanomedicine 5:25-36.
-
(2010)
Int J Nanomedicine
, vol.5
, pp. 25-36
-
-
Holden, C.A.1
Yuan, Q.2
Yeudall, W.A.3
Lebman, D.A.4
Yan, H.5
-
69
-
-
34250803927
-
Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome
-
Hsieh W-C, Chang Y, Hsu M-C, Lan B-S, Hsiao G-C, Chuang H-C, Su I-J. 2007. Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome. Am J Pathol 170(5):1629-1639.
-
(2007)
Am J Pathol
, vol.170
, Issue.5
, pp. 1629-1639
-
-
Hsieh, W.-C.1
Chang, Y.2
Hsu, M.-C.3
Lan, B.-S.4
Hsiao, G.-C.5
Chuang, H.-C.6
Su, I.-J.7
-
70
-
-
0029123596
-
A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity
-
Ippoliti R, Lendaro E, D'Agostino I, Fiani M, Guidarini D, Vestri S, Benedetti P, Brunori M. 1995. A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity. FASEB J 9(12):1220-1225.
-
(1995)
FASEB J
, vol.9
, Issue.12
, pp. 1220-1225
-
-
Ippoliti, R.1
Lendaro, E.2
D'Agostino, I.3
Fiani, M.4
Guidarini, D.5
Vestri, S.6
Benedetti, P.7
Brunori, M.8
-
71
-
-
0043028168
-
RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting
-
Jain S, Mishra V, Singh P, Dubey PK, Saraf DK, Vyas SP. 2003. RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. Int J Pharm 261(1-2):43-55.
-
(2003)
Int J Pharm
, vol.261
, Issue.1-2
, pp. 43-55
-
-
Jain, S.1
Mishra, V.2
Singh, P.3
Dubey, P.K.4
Saraf, D.K.5
Vyas, S.P.6
-
73
-
-
0018537813
-
The important of surface area/volume ratio to the rate of oxygen uptake by red cells
-
Jones D. 1979. The important of surface area/volume ratio to the rate of oxygen uptake by red cells. J Gen Physiol 74(5):643-646.
-
(1979)
J Gen Physiol
, vol.74
, Issue.5
, pp. 643-646
-
-
Jones, D.1
-
74
-
-
0031011598
-
In vitro properties and organ uptake of rat band 3 cross-linked erythrocytes
-
Jordan J, Murciano J, Lotero A, Herraez A, Diez J. 1997. In vitro properties and organ uptake of rat band 3 cross-linked erythrocytes. Biochimie 79(1):53-61.
-
(1997)
Biochimie
, vol.79
, Issue.1
, pp. 53-61
-
-
Jordan, J.1
Murciano, J.2
Lotero, A.3
Herraez, A.4
Diez, J.5
-
75
-
-
67649472398
-
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
-
José B, Sandra MS. 2009. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9(7):463-475.
-
(2009)
Nat Rev Cancer
, vol.9
, Issue.7
, pp. 463-475
-
-
José, B.1
Sandra, M.S.2
-
76
-
-
0037161335
-
Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells
-
Kader A, Pater A. 2002. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells. J Control Release 80(1-3):29-44.
-
(2002)
J Control Release
, vol.80
, Issue.1-3
, pp. 29-44
-
-
Kader, A.1
Pater, A.2
-
77
-
-
63449105836
-
Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes
-
Kapur S, Bonk M. 2009. Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes. P T 34(3):138-141.
-
(2009)
P T
, vol.34
, Issue.3
, pp. 138-141
-
-
Kapur, S.1
Bonk, M.2
-
78
-
-
19944430279
-
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments
-
Kenanova V, Olafsen T, Crow D, Sundaresan G, Subbarayan M, Carter N, Ikle D, Yazaki P, Chatziioannou A, Gambhir S, Williams L, Shively J, Colcher D, Raubitschek A, Wu A. 2005. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res 65(2):622-631.
-
(2005)
Cancer Res
, vol.65
, Issue.2
, pp. 622-631
-
-
Kenanova, V.1
Olafsen, T.2
Crow, D.3
Sundaresan, G.4
Subbarayan, M.5
Carter, N.6
Ikle, D.7
Yazaki, P.8
Chatziioannou, A.9
Gambhir, S.10
Williams, L.11
Shively, J.12
Colcher, D.13
Raubitschek, A.14
Wu, A.15
-
79
-
-
33646255225
-
Polymer-drug conjugates: Progress in polymeric prodrugs
-
Khandare J, Minko T. 2006. Polymer-drug conjugates: Progress in polymeric prodrugs. Progress in Polymer Science 31(4):359-397.
-
(2006)
Progress in Polymer Science
, vol.31
, Issue.4
, pp. 359-397
-
-
Khandare, J.1
Minko, T.2
-
80
-
-
78649928659
-
Improving protein pharmacokinetics by engineering erythrocyte affinity
-
Kontos S, Hubbell J. 2010. Improving protein pharmacokinetics by engineering erythrocyte affinity. Mol Pharm 7(6):2141-2147.
-
(2010)
Mol Pharm
, vol.7
, Issue.6
, pp. 2141-2147
-
-
Kontos, S.1
Hubbell, J.2
-
81
-
-
79953847826
-
INNO-206 (DOXO-EMCH), an albumin-binding prodrug of doxorubicin under development for phase II studies
-
Kratz F. 2011. INNO-206 (DOXO-EMCH), an albumin-binding prodrug of doxorubicin under development for phase II studies. Curr Bioact Compd 7(1):33-38.
-
(2011)
Curr Bioact Compd
, vol.7
, Issue.1
, pp. 33-38
-
-
Kratz, F.1
-
82
-
-
0037028050
-
Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound
-
Kratz F, Warnecke A, Scheuermann K, Stockmar C, Schwab J, Lazar P, Druckes P, Esser N, Drevs J, Rognan D, Bissantz C, Hinderling C, Folkers G, Fichtner I, Unger C. 2002. Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. J Med Chem 45(25):5523-5533.
-
(2002)
J Med Chem
, vol.45
, Issue.25
, pp. 5523-5533
-
-
Kratz, F.1
Warnecke, A.2
Scheuermann, K.3
Stockmar, C.4
Schwab, J.5
Lazar, P.6
Druckes, P.7
Esser, N.8
Drevs, J.9
Rognan, D.10
Bissantz, C.11
Hinderling, C.12
Folkers, G.13
Fichtner, I.14
Unger, C.15
-
83
-
-
0029995124
-
Improved pharmacodynamics of l-asparaginase-loaded in human red blood cells
-
Kravtzoff R, Ropars C, Desbois I, Chassaigne M, Lamagnere JP, Colombat P, Muh JP, Valat C. 1996. Improved pharmacodynamics of l-asparaginase-loaded in human red blood cells. Eur J Clin Pharmacol 49(6):465-470.
-
(1996)
Eur J Clin Pharmacol
, vol.49
, Issue.6
, pp. 465-470
-
-
Kravtzoff, R.1
Ropars, C.2
Desbois, I.3
Chassaigne, M.4
Lamagnere, J.P.5
Colombat, P.6
Muh, J.P.7
Valat, C.8
-
84
-
-
85007107552
-
Future prospectus in targetting drug delivery: A review on resealed erytrocytes-A promising carrier scholars
-
Krishnaveni G, Krishnamoorthy B, Muthukumaran M. 2013. Future prospectus in targetting drug delivery: A review on resealed erytrocytes-A promising carrier scholars. Acad J Pharm 2(2):81-88.
-
(2013)
Acad J Pharm
, vol.2
, Issue.2
, pp. 81-88
-
-
Krishnaveni, G.1
Krishnamoorthy, B.2
Muthukumaran, M.3
-
85
-
-
77958524856
-
Novel anti-tn single-chain Fv-Fc fusion proteins derived from immunized phage library and antibody Fc domain
-
Kubota T, Matsushita T, Niwa R, Kumagai I, Nakamura K. 2010. Novel anti-tn single-chain Fv-Fc fusion proteins derived from immunized phage library and antibody Fc domain. Anticancer Res 30(9):3397-3405.
-
(2010)
Anticancer Res
, vol.30
, Issue.9
, pp. 3397-3405
-
-
Kubota, T.1
Matsushita, T.2
Niwa, R.3
Kumagai, I.4
Nakamura, K.5
-
86
-
-
33845975658
-
Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice
-
Kumar M, Hunag Y, Glinka Y, Prud'homme GJ, Wang Q. 2007. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice. Gene Ther 14(2):162-172.
-
(2007)
Gene Ther
, vol.14
, Issue.2
, pp. 162-172
-
-
Kumar, M.1
Hunag, Y.2
Glinka, Y.3
Prud'homme, G.J.4
Wang, Q.5
-
87
-
-
38649120593
-
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
-
Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. 2008. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 371(9610):395-403.
-
(2008)
Lancet
, vol.371
, Issue.9610
, pp. 395-403
-
-
Kuter, D.J.1
Bussel, J.B.2
Lyons, R.M.3
Pullarkat, V.4
Gernsheimer, T.B.5
Senecal, F.M.6
Aledort, L.M.7
George, J.N.8
Kessler, C.M.9
Sanz, M.A.10
Liebman, H.A.11
Slovick, F.T.12
de Wolf, J.T.13
Bourgeois, E.14
Guthrie Jr., T.H.15
Newland, A.16
Wasser, J.S.17
Hamburg, S.I.18
Grande, C.19
Lefrère, F.20
Lichtin, A.E.21
Tarantino, M.D.22
Terebelo, H.R.23
Viallard, J.F.24
Cuevas, F.J.25
Go, R.S.26
Henry, D.H.27
Redner, R.L.28
Rice, L.29
Schipperus, M.R.30
Guo, D.M.31
Nichol, J.L.32
more..
-
88
-
-
70349322579
-
l-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL)
-
Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, Gitlin SD, David AE, Yang VC. 2009. l-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). J Control Release 139(3):182-189.
-
(2009)
J Control Release
, vol.139
, Issue.3
, pp. 182-189
-
-
Kwon, Y.M.1
Chung, H.S.2
Moon, C.3
Yockman, J.4
Park, Y.J.5
Gitlin, S.D.6
David, A.E.7
Yang, V.C.8
-
89
-
-
71949100459
-
Artemisinin-transferrin conjugate retards growth of breast tumors in the rat
-
Lai H, Nakase I, Lacoste E, Singh N, Sasaki T. 2009. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat. Anticancer Res 29(10):3807-3810.
-
(2009)
Anticancer Res
, vol.29
, Issue.10
, pp. 3807-3810
-
-
Lai, H.1
Nakase, I.2
Lacoste, E.3
Singh, N.4
Sasaki, T.5
-
90
-
-
11844269839
-
Effects of artemisinin-tagged holotransferrin on cancer cells
-
Lai H, Sasaki T, Singh N, Messay A. 2005. Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci 76(11):1267-1279.
-
(2005)
Life Sci
, vol.76
, Issue.11
, pp. 1267-1279
-
-
Lai, H.1
Sasaki, T.2
Singh, N.3
Messay, A.4
-
91
-
-
0031451777
-
Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors
-
Laske D, Youle R, Oldfield E. 1997. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3(12):1362-1368.
-
(1997)
Nat Med
, vol.3
, Issue.12
, pp. 1362-1368
-
-
Laske, D.1
Youle, R.2
Oldfield, E.3
-
92
-
-
0019775835
-
The sequence of human serum albumin cDNA and its expression in E. coli
-
Lawn R, Adelman J, Bock S, Franke A, Houck C, Najarian R, Seeburg P, Wion K. 1981. The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res 9(22):6103-6114.
-
(1981)
Nucleic Acids Res
, vol.9
, Issue.22
, pp. 6103-6114
-
-
Lawn, R.1
Adelman, J.2
Bock, S.3
Franke, A.4
Houck, C.5
Najarian, R.6
Seeburg, P.7
Wion, K.8
-
93
-
-
22644434396
-
Synthesis and biological evaluation of E C72: A new folate-targeted chemotherapeutic
-
Leamon CP, Reddy JA, Vlahov IR, Vetzel M, Parker N, Nicoson JS, Xu L-C, Westrick E. 2005. Synthesis and biological evaluation of E C72: A new folate-targeted chemotherapeutic. Bioconjug Chem 16(4):803-811.
-
(2005)
Bioconjug Chem
, vol.16
, Issue.4
, pp. 803-811
-
-
Leamon, C.P.1
Reddy, J.A.2
Vlahov, I.R.3
Vetzel, M.4
Parker, N.5
Nicoson, J.S.6
Xu, L.-C.7
Westrick, E.8
-
94
-
-
34247158645
-
Expression and characterization of human growth hormone-Fc fusion proteins for transcytosis induction
-
Lee C, Woo J, Cho K, Kang S, Kang S, Choi Y. 2007. Expression and characterization of human growth hormone-Fc fusion proteins for transcytosis induction. Biotechnol Appl Biochem 46(Pt 4):211-217.
-
(2007)
Biotechnol Appl Biochem
, vol.46
, Issue.PART. 4
, pp. 211-217
-
-
Lee, C.1
Woo, J.2
Cho, K.3
Kang, S.4
Kang, S.5
Choi, Y.6
-
95
-
-
84890900104
-
Etanercept for the treatment of rheumatoid arthritis
-
Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA. 2013. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 31(5).
-
(2013)
Cochrane Database Syst Rev
, vol.31
, Issue.5
-
-
Lethaby, A.1
Lopez-Olivo, M.A.2
Maxwell, L.3
Burls, A.4
Tugwell, P.5
Wells, G.A.6
-
96
-
-
24044461733
-
Macrophage responses to hypoxia: Implications for tumor progression and anti-cancer therapies
-
Lewis C, Murdoch C. 2005. Macrophage responses to hypoxia: Implications for tumor progression and anti-cancer therapies. Am J Pathol 167(3):627-635.
-
(2005)
Am J Pathol
, vol.167
, Issue.3
, pp. 627-635
-
-
Lewis, C.1
Murdoch, C.2
-
97
-
-
84862790727
-
A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas
-
Li Y, He H, Jia X, Lu W-L, Lou J, Wei Y. 2012. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials 33(15):3899-3908.
-
(2012)
Biomaterials
, vol.33
, Issue.15
, pp. 3899-3908
-
-
Li, Y.1
He, H.2
Jia, X.3
Lu, W.-L.4
Lou, J.5
Wei, Y.6
-
98
-
-
84886963876
-
Lipids: Absorption and Transport
-
In: Erdman J, MacDonald I, Zeisel S. Oxford, UK: Wiley-Blackwell.
-
Lichtenstein AH, Jones PJH. 2012. Lipids: Absorption and Transport. In: Erdman J, MacDonald I, Zeisel S. Present Knowledge in Nutrition. Oxford, UK: Wiley-Blackwell. p 118-131.
-
(2012)
Present Knowledge in Nutrition
, pp. 118-131
-
-
Lichtenstein, A.H.1
Jones, P.J.H.2
-
99
-
-
45749083773
-
Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
-
Liong M, Lu J, Kovochich M, Xia T, Ruehm S, Nel A, Tamanoi F, Zink J. 2008. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5):889-896.
-
(2008)
ACS Nano
, vol.2
, Issue.5
, pp. 889-896
-
-
Liong, M.1
Lu, J.2
Kovochich, M.3
Xia, T.4
Ruehm, S.5
Nel, A.6
Tamanoi, F.7
Zink, J.8
-
100
-
-
13444250281
-
-
San Diego, CA, United States: Elsevier Academic Press.
-
Litwack G. 2008. Folic acid and folates. San Diego, CA, United States: Elsevier Academic Press.
-
(2008)
Folic acid and folates
-
-
Litwack, G.1
-
101
-
-
84967546704
-
Lipoproteins as pharmaceutical carriers
-
In: Torchilin V. London, UK: Imperial College Press
-
Liu S, Wang S, Lu R. 2006. Lipoproteins as pharmaceutical carriers. In: Torchilin V. Nanoparticulates as drug carriers. London, UK: Imperial College Press. p 173-186.
-
(2006)
Nanoparticulates as drug carriers
, pp. 173-186
-
-
Liu, S.1
Wang, S.2
Lu, R.3
-
102
-
-
0037451745
-
Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells
-
Lotero L, Olmos G, Diez J. 2003. Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells. Biochim Biophys Acta 1620(1-3):160-166.
-
(2003)
Biochim Biophys Acta
, vol.1620
, Issue.1-3
, pp. 160-166
-
-
Lotero, L.1
Olmos, G.2
Diez, J.3
-
103
-
-
85007107314
-
Heterodimeric follicle stimulating hormone-fc (fsh-fc) fusion proteins for the treatment of infertility
-
Low SC. 2005. Heterodimeric follicle stimulating hormone-fc (fsh-fc) fusion proteins for the treatment of infertility. Google Patents.
-
(2005)
Google Patents
-
-
Low, S.C.1
-
104
-
-
58949093276
-
Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells
-
Lubgan D, Jozwiak Z, Grabenbauer G, Distel L. 2009. Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells. Cell Mol Biol Lett 14(1):113-127.
-
(2009)
Cell Mol Biol Lett
, vol.14
, Issue.1
, pp. 113-127
-
-
Lubgan, D.1
Jozwiak, Z.2
Grabenbauer, G.3
Distel, L.4
-
105
-
-
42449138655
-
Curbing the appetites of the big eaters
-
Luft F. 2008. Curbing the appetites of the big eaters. J Mol Med 86(4):351-352.
-
(2008)
J Mol Med
, vol.86
, Issue.4
, pp. 351-352
-
-
Luft, F.1
-
106
-
-
84870391160
-
Transferrin-cisplatin specifically deliver cisplatin to HepG2 cells in vitro and enhance cisplatin cytotoxicity
-
Luo L-Z, Jin H-W, Huang H-Q. 2012a. Transferrin-cisplatin specifically deliver cisplatin to HepG2 cells in vitro and enhance cisplatin cytotoxicity. J Proteomics 77:237-250.
-
(2012)
J Proteomics
, vol.77
, pp. 237-250
-
-
Luo, L.-Z.1
Jin, H.-W.2
Huang, H.-Q.3
-
107
-
-
84857633697
-
Engineering of erythrocyte-based drug carriers: Control of protein release and bioactivity
-
Luo R, Mutukumaraswamy S, Venkatraman S, Neu B. 2012b. Engineering of erythrocyte-based drug carriers: Control of protein release and bioactivity. J Mater Sci Mater Med 23(1):63-71.
-
(2012)
J Mater Sci Mater Med
, vol.23
, Issue.1
, pp. 63-71
-
-
Luo, R.1
Mutukumaraswamy, S.2
Venkatraman, S.3
Neu, B.4
-
108
-
-
77954926895
-
Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery
-
MacEwan S, Callahan D, Chilkoti A. 2010. Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine (Lond) 5(5):793-806.
-
(2010)
Nanomedicine (Lond)
, vol.5
, Issue.5
, pp. 793-806
-
-
MacEwan, S.1
Callahan, D.2
Chilkoti, A.3
-
109
-
-
0346690404
-
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression
-
Magnani M, Balestra E, Fraternale A, Aquaro S, Paiardini M, Cervasi B, Casabianca A, Garaci E, Perno C-F. 2003. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. J Leukoc Biol 74(5):764-771.
-
(2003)
J Leukoc Biol
, vol.74
, Issue.5
, pp. 764-771
-
-
Magnani, M.1
Balestra, E.2
Fraternale, A.3
Aquaro, S.4
Paiardini, M.5
Cervasi, B.6
Casabianca, A.7
Garaci, E.8
Perno, C.-F.9
-
110
-
-
0029120149
-
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5′-triphosphate
-
Magnani M, Cassabianca A, Rossi L, Fraternale A, Brandi G, Silvotti L, Piedimonte G. 1995. Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5′-triphosphate. Antiviral Chem Chemother 6(5):312-319.
-
(1995)
Antiviral Chem Chemother
, vol.6
, Issue.5
, pp. 312-319
-
-
Magnani, M.1
Cassabianca, A.2
Rossi, L.3
Fraternale, A.4
Brandi, G.5
Silvotti, L.6
Piedimonte, G.7
-
111
-
-
0026936332
-
Red blood cells as an antigen-delivery system
-
Magnani M, Chiarantini L, Vittoria E, Mancini U, Rossi L, Fazi A. 1992a. Red blood cells as an antigen-delivery system. Biotechnol Appl Biochem 16(2):188-194.
-
(1992)
Biotechnol Appl Biochem
, vol.16
, Issue.2
, pp. 188-194
-
-
Magnani, M.1
Chiarantini, L.2
Vittoria, E.3
Mancini, U.4
Rossi, L.5
Fazi, A.6
-
112
-
-
0026770371
-
Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: In vitro and in vivo studies
-
Magnani M, Rossi L, Brandi G, Schiavano GF, Montroni M, Piedimonte G. 1992b. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: In vitro and in vivo studies. Proc Natl Acad Sci 89(14):6477-6481.
-
(1992)
Proc Natl Acad Sci
, vol.89
, Issue.14
, pp. 6477-6481
-
-
Magnani, M.1
Rossi, L.2
Brandi, G.3
Schiavano, G.F.4
Montroni, M.5
Piedimonte, G.6
-
114
-
-
77954634088
-
Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer
-
Matsui M, Shimizu Y, Kodera Y, Kondo E, Ikehara Y, Nakanishi H. 2010. Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer. Cancer Sci 101(7):1670-1677.
-
(2010)
Cancer Sci
, vol.101
, Issue.7
, pp. 1670-1677
-
-
Matsui, M.1
Shimizu, Y.2
Kodera, Y.3
Kondo, E.4
Ikehara, Y.5
Nakanishi, H.6
-
115
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
-
Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1):6387-6392.
-
(1986)
Cancer Res
, vol.46
, Issue.12 PART. 1
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
-
116
-
-
0021365844
-
Potential role of platelets in the pathogenesis of tumor metastasis
-
Mehta P. 1984. Potential role of platelets in the pathogenesis of tumor metastasis. Blood 63(1):55-63.
-
(1984)
Blood
, vol.63
, Issue.1
, pp. 55-63
-
-
Mehta, P.1
-
117
-
-
77949275122
-
Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications
-
Menjoge A, Kannan R, Tomalia D. 2010. Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications. Drug Discov Today 15(5-6):171-185.
-
(2010)
Drug Discov Today
, vol.15
, Issue.5-6
, pp. 171-185
-
-
Menjoge, A.1
Kannan, R.2
Tomalia, D.3
-
118
-
-
84858718379
-
Atrial natriuretic peptide-Fc, ANP-Fc, fusion proteins: semisynthesis, in vitro activity and pharmacokinetics in rats
-
Mezo AR, McDonnell KA, Low SC, Song J, Reidy TJ, Lu Q, Amari JV, Hoehn T, Peters RT, Dumont J, Bitonti AJ. 2012. Atrial natriuretic peptide-Fc, ANP-Fc, fusion proteins: semisynthesis, in vitro activity and pharmacokinetics in rats. Bioconjug Chem 23(3):518-526.
-
(2012)
Bioconjug Chem
, vol.23
, Issue.3
, pp. 518-526
-
-
Mezo, A.R.1
McDonnell, K.A.2
Low, S.C.3
Song, J.4
Reidy, T.J.5
Lu, Q.6
Amari, J.V.7
Hoehn, T.8
Peters, R.T.9
Dumont, J.10
Bitonti, A.J.11
-
119
-
-
84858333416
-
Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates
-
Millington T, Koulmanda M, Ng C, Boskovic S, Nadazdin O, Benichou G, Zheng X, Strom T, Madsen J. 2012. Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates. J Heart Lung Transplant 31(4):427-435.
-
(2012)
J Heart Lung Transplant
, vol.31
, Issue.4
, pp. 427-435
-
-
Millington, T.1
Koulmanda, M.2
Ng, C.3
Boskovic, S.4
Nadazdin, O.5
Benichou, G.6
Zheng, X.7
Strom, T.8
Madsen, J.9
-
120
-
-
0033638014
-
Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake
-
Mishra PR, Jain NK. 2000. Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake. J Drug Target 8(4):217-224.
-
(2000)
J Drug Target
, vol.8
, Issue.4
, pp. 217-224
-
-
Mishra, P.R.1
Jain, N.K.2
-
121
-
-
77954512738
-
Proteomics retrenches
-
Mitchell P. 2010. Proteomics retrenches. Nat Biotechnol 28(7):665-670.
-
(2010)
Nat Biotechnol
, vol.28
, Issue.7
, pp. 665-670
-
-
Mitchell, P.1
-
123
-
-
0036634979
-
Platelets and cancer
-
Nash G, Turner L, Scully M, Kakkar A. 2002. Platelets and cancer. Lancet Oncol 3(7):425-430.
-
(2002)
Lancet Oncol
, vol.3
, Issue.7
, pp. 425-430
-
-
Nash, G.1
Turner, L.2
Scully, M.3
Kakkar, A.4
-
124
-
-
34250311499
-
Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme
-
Nikanjam M, Blakely E, Bjornstad K, Shu X, Budinger T, Forte T. 2007. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme. Int J Pharm 328(1):86-94.
-
(2007)
Int J Pharm
, vol.328
, Issue.1
, pp. 86-94
-
-
Nikanjam, M.1
Blakely, E.2
Bjornstad, K.3
Shu, X.4
Budinger, T.5
Forte, T.6
-
125
-
-
0026575708
-
Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes
-
Ninfali P, Rossi L, Baronciani L, Tirillini B, Ropars C, Magnani M. 1992. Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes. Alcohol Alcohol 27(1):19-23.
-
(1992)
Alcohol Alcohol
, vol.27
, Issue.1
, pp. 19-23
-
-
Ninfali, P.1
Rossi, L.2
Baronciani, L.3
Tirillini, B.4
Ropars, C.5
Magnani, M.6
-
126
-
-
84905060986
-
-
Celtic Pharma Terminates Transmid Trial KSB311R/CIII/001.
-
Noonan M. 2007. Celtic Pharma Terminates Transmid Trial KSB311R/CIII/001.
-
(2007)
-
-
Noonan, M.1
-
127
-
-
57749092893
-
Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide
-
Oh S, Kim B, Singh N, Lai H, Sasaki T. 2009. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Cancer Lett 274(1):33-39.
-
(2009)
Cancer Lett
, vol.274
, Issue.1
, pp. 33-39
-
-
Oh, S.1
Kim, B.2
Singh, N.3
Lai, H.4
Sasaki, T.5
-
128
-
-
14644392093
-
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
-
Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. 2005. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338(2):284-293.
-
(2005)
Anal Biochem
, vol.338
, Issue.2
, pp. 284-293
-
-
Parker, N.1
Turk, M.J.2
Westrick, E.3
Lewis, J.D.4
Low, P.S.5
Leamon, C.P.6
-
129
-
-
1942503257
-
Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis
-
Paulos CM, Turk MJ, Breur GJ, Low PS. 2004. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 56(8):1205-1217.
-
(2004)
Adv Drug Deliv Rev
, vol.56
, Issue.8
, pp. 1205-1217
-
-
Paulos, C.M.1
Turk, M.J.2
Breur, G.J.3
Low, P.S.4
-
130
-
-
0025827590
-
A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity
-
Peppel K, Crawford D, Beutler B. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 174(6):1483-1489.
-
(1991)
J Exp Med
, vol.174
, Issue.6
, pp. 1483-1489
-
-
Peppel, K.1
Crawford, D.2
Beutler, B.3
-
131
-
-
84873043409
-
Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein
-
Peters R, Toby G, Lu Q, Liu T, Kulman J, Low S, Bitonti A, Pierce G. 2013. Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein. J Thromb Haemost 11(1):132-141.
-
(2013)
J Thromb Haemost
, vol.11
, Issue.1
, pp. 132-141
-
-
Peters, R.1
Toby, G.2
Lu, Q.3
Liu, T.4
Kulman, J.5
Low, S.6
Bitonti, A.7
Pierce, G.8
-
133
-
-
84934434290
-
Engineering peptide therapeutics using MIMETIBODY™ technology
-
Picha K, Huang C, Bugelski P, O'Neil K. 2014. Engineering peptide therapeutics using MIMETIBODY™ technology. Methods Mol Biol 1088:125-145.
-
(2014)
Methods Mol Biol
, vol.1088
, pp. 125-145
-
-
Picha, K.1
Huang, C.2
Bugelski, P.3
O'Neil, K.4
-
134
-
-
0021061849
-
Encapsulation of drugs in intact erythrocytes: An intravenous delivery system
-
Pitt E, Johnson CM, Lewis DA, Jenner DA, Offord RE. 1983. Encapsulation of drugs in intact erythrocytes: An intravenous delivery system. Biochem Pharmacol 32(22):3359-3368.
-
(1983)
Biochem Pharmacol
, vol.32
, Issue.22
, pp. 3359-3368
-
-
Pitt, E.1
Johnson, C.M.2
Lewis, D.A.3
Jenner, D.A.4
Offord, R.E.5
-
136
-
-
0024345664
-
Production of recombinant human serum albumin from Saccharomyces cerevisiae
-
Quirk A, Geisow M, Woodrow J, Burton S, Wood P, Sutton A, Johnson R, Dodsworth N. 1989. Production of recombinant human serum albumin from Saccharomyces cerevisiae. Biotechnol Appl Biochem 11(3):273-287.
-
(1989)
Biotechnol Appl Biochem
, vol.11
, Issue.3
, pp. 273-287
-
-
Quirk, A.1
Geisow, M.2
Woodrow, J.3
Burton, S.4
Wood, P.5
Sutton, A.6
Johnson, R.7
Dodsworth, N.8
-
137
-
-
79955481749
-
Exosomes as intercellular signalosomes and pharmacological effectors
-
Record M, Subra C, Silvente-Poirot S, Poirot M. 2011. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81(10):1171-1182.
-
(2011)
Biochem Pharmacol
, vol.81
, Issue.10
, pp. 1171-1182
-
-
Record, M.1
Subra, C.2
Silvente-Poirot, S.3
Poirot, M.4
-
138
-
-
33646488331
-
Folate receptor specific anti-tumor activity of folate-mitomycin conjugates
-
Reddy J, Westrick E, Vlahov I, Howard S, Santhapuram H, Leamon C. 2006. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates. Cancer Chemother Pharmacol 58(2):229-236.
-
(2006)
Cancer Chemother Pharmacol
, vol.58
, Issue.2
, pp. 229-236
-
-
Reddy, J.1
Westrick, E.2
Vlahov, I.3
Howard, S.4
Santhapuram, H.5
Leamon, C.6
-
139
-
-
84855998214
-
Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia
-
Redman CWG, Tannetta DS, Dragovic RA, Gardiner C, Southcombe JH, Collett GP, Sargent IL. 2012. Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 33(Suppl.):S48-S54.
-
(2012)
Placenta
, vol.33
, Issue.SUPPL.
-
-
Redman, C.W.G.1
Tannetta, D.S.2
Dragovic, R.A.3
Gardiner, C.4
Southcombe, J.H.5
Collett, G.P.6
Sargent, I.L.7
-
140
-
-
84993913350
-
Selective liver targeting of antivirals by recombinant chylomicrons-A new therapeutic approach to hepatitis B
-
Rensen P, van Dijk M, Havenaar E, Bijsterbosch M, Kruijt J, van Berkel T. 1995. Selective liver targeting of antivirals by recombinant chylomicrons-A new therapeutic approach to hepatitis B. Nat Med 1(3):221-225.
-
(1995)
Nat Med
, vol.1
, Issue.3
, pp. 221-225
-
-
Rensen, P.1
van Dijk, M.2
Havenaar, E.3
Bijsterbosch, M.4
Kruijt, J.5
van Berkel, T.6
-
141
-
-
67349137868
-
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
-
Richardson D, Kalinowski D, Lau S, Jansson P, Lovejoy D. 2009. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta 1790(7):702-717.
-
(2009)
Biochim Biophys Acta
, vol.1790
, Issue.7
, pp. 702-717
-
-
Richardson, D.1
Kalinowski, D.2
Lau, S.3
Jansson, P.4
Lovejoy, D.5
-
142
-
-
85013842944
-
-
Oxford, UK: Elsevier
-
Ridgway N, McLeod R, Vance JE, Vance D. 2008. Biochemistry of lipids, lipoproteins and membranes. Oxford, UK: Elsevier. p 624.
-
(2008)
Biochemistry of lipids, lipoproteins and membranes
, pp. 624
-
-
Ridgway, N.1
McLeod, R.2
Vance, J.E.3
Vance, D.4
-
144
-
-
34548229364
-
FcRn: The neonatal Fc receptor comes of age
-
Roopenian D, Akilesh S. 2007. FcRn: The neonatal Fc receptor comes of age. Nat Rev Immunol 7(9):715-725.
-
(2007)
Nat Rev Immunol
, vol.7
, Issue.9
, pp. 715-725
-
-
Roopenian, D.1
Akilesh, S.2
-
145
-
-
20244385810
-
Macrophage depletion induced by clodronate-loaded erythrocytes
-
Rossi L, Serafini S, Antonelli A, Pierigé F, Carnevali A, Battistelli V, Malatesta M, Balestra E, Caliò R, Perno C-F., et al. 2005. Macrophage depletion induced by clodronate-loaded erythrocytes. J Drug Target 13(2):99-111.
-
(2005)
J Drug Target
, vol.13
, Issue.2
, pp. 99-111
-
-
Rossi, L.1
Serafini, S.2
Antonelli, A.3
Pierigé, F.4
Carnevali, A.5
Battistelli, V.6
Malatesta, M.7
Balestra, E.8
Caliò, R.9
Perno, C.-F.10
-
146
-
-
73349127491
-
Liraglutide in type 2 diabetes: From pharmacological development to clinical practice
-
Rossi M, Nicolucci A. 2009. Liraglutide in type 2 diabetes: From pharmacological development to clinical practice. Acta Biomed 80(2):93-101.
-
(2009)
Acta Biomed
, vol.80
, Issue.2
, pp. 93-101
-
-
Rossi, M.1
Nicolucci, A.2
-
149
-
-
65549147617
-
Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women
-
Ruckle J, Jacobs M, Kramer W, Pearsall A, Kumar R, Underwood K, Seehra J, Yang Y, Condon C, Sherman M. 2009. Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women. J Bone Miner Res 24(4):744-752.
-
(2009)
J Bone Miner Res
, vol.24
, Issue.4
, pp. 744-752
-
-
Ruckle, J.1
Jacobs, M.2
Kramer, W.3
Pearsall, A.4
Kumar, R.5
Underwood, K.6
Seehra, J.7
Yang, Y.8
Condon, C.9
Sherman, M.10
-
150
-
-
84886087036
-
Drug delivery using platelet cancer cell interaction
-
Sarkar S, Alam MA, Shaw J, Dasgupta AK. 2013. Drug delivery using platelet cancer cell interaction. Pharm Res 30(11):2785-2794.
-
(2013)
Pharm Res
, vol.30
, Issue.11
, pp. 2785-2794
-
-
Sarkar, S.1
Alam, M.A.2
Shaw, J.3
Dasgupta, A.K.4
-
151
-
-
66549127370
-
CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools
-
Sathyanarayana P, Houde E, Marshall D, Volk A, Makropoulos D, Emerson C, Pradeep A, Bugelski P, Wojchowski D. 2009. CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools. Blood 113(20):4955-4962.
-
(2009)
Blood
, vol.113
, Issue.20
, pp. 4955-4962
-
-
Sathyanarayana, P.1
Houde, E.2
Marshall, D.3
Volk, A.4
Makropoulos, D.5
Emerson, C.6
Pradeep, A.7
Bugelski, P.8
Wojchowski, D.9
-
152
-
-
44149103399
-
Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker
-
Satyam A. 2008. Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker. Bioorg Med Chem Lett 18(11):3196-3199.
-
(2008)
Bioorg Med Chem Lett
, vol.18
, Issue.11
, pp. 3196-3199
-
-
Satyam, A.1
-
153
-
-
0023274371
-
Secretion of human serum albumin from Bacillus subtilis
-
Saunders C, Schmidt B, Mallonee R, Guyer M. 1987. Secretion of human serum albumin from Bacillus subtilis. J Bacteriol 169(7):2917-2925.
-
(1987)
J Bacteriol
, vol.169
, Issue.7
, pp. 2917-2925
-
-
Saunders, C.1
Schmidt, B.2
Mallonee, R.3
Guyer, M.4
-
154
-
-
0026608797
-
gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis
-
Schnitzer J. 1992. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol 262(1 Pt 2):54.
-
(1992)
Am J Physiol
, vol.262
, Issue.1 PART. 2
, pp. 54
-
-
Schnitzer, J.1
-
155
-
-
1842789675
-
Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins
-
Seki J, Sonoke S, Saheki A, Koike T, Fukui H, Doi M, Mayumi T. 2004. Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins. Int J Pharm 275(1-2):239-248.
-
(2004)
Int J Pharm
, vol.275
, Issue.1-2
, pp. 239-248
-
-
Seki, J.1
Sonoke, S.2
Saheki, A.3
Koike, T.4
Fukui, H.5
Doi, M.6
Mayumi, T.7
-
158
-
-
84887211051
-
A phase I study of EC0225 administered weeks 1 and 2 of a 4-week cycle
-
Sharma S, Sausville E, LoRusso P, Vogelzang N, Samlowski W, Carter J, Forman K, Bever S, Messmann R. 2010. A phase I study of EC0225 administered weeks 1 and 2 of a 4-week cycle. p 3082.
-
(2010)
, pp. 3082
-
-
Sharma, S.1
Sausville, E.2
LoRusso, P.3
Vogelzang, N.4
Samlowski, W.5
Carter, J.6
Forman, K.7
Bever, S.8
Messmann, R.9
-
159
-
-
0036282757
-
VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting
-
Shawer M, Greenspan P, Øie S, Lu DR. 2002. VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting. J Pharm Sci 91(6):1405-1413.
-
(2002)
J Pharm Sci
, vol.91
, Issue.6
, pp. 1405-1413
-
-
Shawer, M.1
Greenspan, P.2
Øie, S.3
Lu, D.R.4
-
160
-
-
33846453333
-
Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A
-
Shi Q, Wilcox D, Fahs S, Fang J, Johnson B, Du L, Desai D, Montgomery R. 2007. Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A. J Thromb Haemost 5(2):352-361.
-
(2007)
J Thromb Haemost
, vol.5
, Issue.2
, pp. 352-361
-
-
Shi, Q.1
Wilcox, D.2
Fahs, S.3
Fang, J.4
Johnson, B.5
Du, L.6
Desai, D.7
Montgomery, R.8
-
161
-
-
13244262627
-
Targeting platelet GPIbalpha transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbbeta and GPIX
-
Shi Q, Wilcox D, Morateck P, Fahs S, Kenny D, Montgomery R. 2004. Targeting platelet GPIbalpha transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbbeta and GPIX. J Thromb Haemost 2(11):1989-1997.
-
(2004)
J Thromb Haemost
, vol.2
, Issue.11
, pp. 1989-1997
-
-
Shi, Q.1
Wilcox, D.2
Morateck, P.3
Fahs, S.4
Kenny, D.5
Montgomery, R.6
-
162
-
-
84866565943
-
Peptibodies: A flexible alternative format to antibodies
-
Shimamoto G, Gegg C, Boone T, Quéva C. 2012. Peptibodies: A flexible alternative format to antibodies. mAbs 4(5):586-591.
-
(2012)
mAbs
, vol.4
, Issue.5
, pp. 586-591
-
-
Shimamoto, G.1
Gegg, C.2
Boone, T.3
Quéva, C.4
-
163
-
-
14744273526
-
Saccharomyces cerevisiae strains that overexpress heterologous proteins
-
Sleep D, Belfield G, Ballance D, Steven J, Jones S, Evans L, Moir P, Goodey A. 1991. Saccharomyces cerevisiae strains that overexpress heterologous proteins. Bio/technology (Nature Publishing Company) 9(2):183-187.
-
(1991)
Bio/technology (Nature Publishing Company)
, vol.9
, Issue.2
, pp. 183-187
-
-
Sleep, D.1
Belfield, G.2
Ballance, D.3
Steven, J.4
Jones, S.5
Evans, L.6
Moir, P.7
Goodey, A.8
-
164
-
-
11944261204
-
The secretion of human serum albumin from the yeast Saccharomyces cerevisiae using five different leader sequences
-
Sleep D, Belfield G, Goodey A. 1990. The secretion of human serum albumin from the yeast Saccharomyces cerevisiae using five different leader sequences. Bio/technology (Nature Publishing Company) 8(1):42-46.
-
(1990)
Bio/technology (Nature Publishing Company)
, vol.8
, Issue.1
, pp. 42-46
-
-
Sleep, D.1
Belfield, G.2
Goodey, A.3
-
165
-
-
84885370061
-
Albumin as a versatile platform for drug half-life extension
-
Sleep D, Cameron J, Evans L. 2013. Albumin as a versatile platform for drug half-life extension. Biochim Biophys Acta 1830(12):5526-5534.
-
(2013)
Biochim Biophys Acta
, vol.1830
, Issue.12
, pp. 5526-5534
-
-
Sleep, D.1
Cameron, J.2
Evans, L.3
-
166
-
-
38049090659
-
Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain
-
Soni V, Kohli DV, Jain SK. 2008. Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain. J Drug Target 16(1):73-78.
-
(2008)
J Drug Target
, vol.16
, Issue.1
, pp. 73-78
-
-
Soni, V.1
Kohli, D.V.2
Jain, S.K.3
-
167
-
-
0035083954
-
Receptor mediated endocytosis and cytotoxicity of transferrin-mitomycin C conjugate in the HepG2 cell and primary cultured rat hepatocyte
-
Tanaka T, Fujishima Y, Kaneo Y. 2001. Receptor mediated endocytosis and cytotoxicity of transferrin-mitomycin C conjugate in the HepG2 cell and primary cultured rat hepatocyte. Biol Pharm Bull 24(3):268-273.
-
(2001)
Biol Pharm Bull
, vol.24
, Issue.3
, pp. 268-273
-
-
Tanaka, T.1
Fujishima, Y.2
Kaneo, Y.3
-
168
-
-
33751204171
-
Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium
-
Temming K, Lacombe M, Schaapveld R, Orfi L, Kéri G, Poelstra K, Molema G, Kok R. 2006. Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium. Chem Med Chem 1(11):1200-1203.
-
(2006)
Chem Med Chem
, vol.1
, Issue.11
, pp. 1200-1203
-
-
Temming, K.1
Lacombe, M.2
Schaapveld, R.3
Orfi, L.4
Kéri, G.5
Poelstra, K.6
Molema, G.7
Kok, R.8
-
169
-
-
70349451255
-
Ligand-targeted delivery of small interfering rnas to malignant cells and tissues
-
Thomas M, Kularatne SA, Qi L, Kleindl P, Leamon CP, Hansen MJ, Low PS. 2009. Ligand-targeted delivery of small interfering rnas to malignant cells and tissues. Ann N Y Acad Sci 1175(1):32-39.
-
(2009)
Ann N Y Acad Sci
, vol.1175
, Issue.1
, pp. 32-39
-
-
Thomas, M.1
Kularatne, S.A.2
Qi, L.3
Kleindl, P.4
Leamon, C.P.5
Hansen, M.J.6
Low, P.S.7
-
170
-
-
84874874434
-
Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
-
Thomas M, Mousa S, Mousa S. 2013. Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration. Clin Ophthalmol 7:495-501.
-
(2013)
Clin Ophthalmol
, vol.7
, pp. 495-501
-
-
Thomas, M.1
Mousa, S.2
Mousa, S.3
-
171
-
-
84905008773
-
Long-acting growth hormone analogues
-
In: Ho K, editor. New York, NY, United States: Springer-Verlag
-
Thorpe A, Freeman H, Pradhananga SL, Wilkinson IR, Ross RJM. 2011. Long-acting growth hormone analogues. In: Ho K, editor. Growth hormone related diseases and therapy: A molecular and physiological perspective for the clinician. New York, NY, United States: Springer-Verlag. p 361-373.
-
(2011)
Growth hormone related diseases and therapy: A molecular and physiological perspective for the clinician
, pp. 361-373
-
-
Thorpe, A.1
Freeman, H.2
Pradhananga, S.L.3
Wilkinson, I.R.4
Ross, R.J.M.5
-
172
-
-
84869841559
-
Comparison of two flow-based imaging methods to measure individual red blood cell area and volume
-
Tomaiuolo G, Rossi D, Caserta S, Cesarelli M, Guido S. 2012. Comparison of two flow-based imaging methods to measure individual red blood cell area and volume. Cytometry A 81(12):1040-1047.
-
(2012)
Cytometry A
, vol.81
, Issue.12
, pp. 1040-1047
-
-
Tomaiuolo, G.1
Rossi, D.2
Caserta, S.3
Cesarelli, M.4
Guido, S.5
-
173
-
-
0019874126
-
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles
-
Trams E, Lauter C, Salem N, Heine U. 1981. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 645(1):63-70.
-
(1981)
Biochim Biophys Acta
, vol.645
, Issue.1
, pp. 63-70
-
-
Trams, E.1
Lauter, C.2
Salem, N.3
Heine, U.4
-
174
-
-
84879147391
-
Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery
-
Tsuji T, Yoshitomi H, Usukura J. 2013. Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery. Microscopy 62(3):341-352.
-
(2013)
Microscopy
, vol.62
, Issue.3
, pp. 341-352
-
-
Tsuji, T.1
Yoshitomi, H.2
Usukura, J.3
-
175
-
-
59649102668
-
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)
-
Ulbrich K, Hekmatara T, Herbert E, Kreuter J. 2009. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm 71(2):251-256.
-
(2009)
Eur J Pharm Biopharm
, vol.71
, Issue.2
, pp. 251-256
-
-
Ulbrich, K.1
Hekmatara, T.2
Herbert, E.3
Kreuter, J.4
-
176
-
-
84859553266
-
Pulmonary administration of interferon Beta-1a-fc fusion protein in non-human primates using an immunoglobulin transport pathway
-
Vallee S, Rakhe S, Reidy T, Walker S, Lu Q, Sakorafas P, Low S, Bitonti A. 2012. Pulmonary administration of interferon Beta-1a-fc fusion protein in non-human primates using an immunoglobulin transport pathway. J Interferon Cytokine Res 32(4):178-184.
-
(2012)
J Interferon Cytokine Res
, vol.32
, Issue.4
, pp. 178-184
-
-
Vallee, S.1
Rakhe, S.2
Reidy, T.3
Walker, S.4
Lu, Q.5
Sakorafas, P.6
Low, S.7
Bitonti, A.8
-
178
-
-
33747349484
-
Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide
-
Vlahov IR, Santhapuram HKR, Kleindl PJ, Howard SJ, Stanford KM, Leamon CP. 2006. Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide. Bioorg Med Chem Lett 16(19):5093-5096.
-
(2006)
Bioorg Med Chem Lett
, vol.16
, Issue.19
, pp. 5093-5096
-
-
Vlahov, I.R.1
Santhapuram, H.K.R.2
Kleindl, P.J.3
Howard, S.J.4
Stanford, K.M.5
Leamon, C.P.6
-
179
-
-
0034734960
-
Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
-
Vyas SP, Sihorkar V. 2000. Endogenous carriers and ligands in non-immunogenic site-specific drug delivery. Adv Drug Deliv Rev 43(2-3):101-164.
-
(2000)
Adv Drug Deliv Rev
, vol.43
, Issue.2-3
, pp. 101-164
-
-
Vyas, S.P.1
Sihorkar, V.2
-
180
-
-
77951743418
-
Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites
-
Wang GP, Guan YS, Jin XR, Jiang SS, Lu ZJ, Wu Y, Li Y, Li M, Luo F. 2010. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites. J Gastroenterol Hepatol 25(5):985-990.
-
(2010)
J Gastroenterol Hepatol
, vol.25
, Issue.5
, pp. 985-990
-
-
Wang, G.P.1
Guan, Y.S.2
Jin, X.R.3
Jiang, S.S.4
Lu, Z.J.5
Wu, Y.6
Li, Y.7
Li, M.8
Luo, F.9
-
181
-
-
79960363229
-
More effective nanomedicines through particle design
-
Wang J, Byrne JD, Napier ME, DeSimone JM. 2011. More effective nanomedicines through particle design. Small 7(14):1919-1931.
-
(2011)
Small
, vol.7
, Issue.14
, pp. 1919-1931
-
-
Wang, J.1
Byrne, J.D.2
Napier, M.E.3
DeSimone, J.M.4
-
182
-
-
0030611096
-
Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical
-
Wang S, Luo J, Lantrip DA, Waters DJ, Mathias CJ, Green MA, Fuchs PL, Low PS. 1997. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjug Chem 8(5):673-679.
-
(1997)
Bioconjug Chem
, vol.8
, Issue.5
, pp. 673-679
-
-
Wang, S.1
Luo, J.2
Lantrip, D.A.3
Waters, D.J.4
Mathias, C.J.5
Green, M.A.6
Fuchs, P.L.7
Low, P.S.8
-
183
-
-
0344876636
-
Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas
-
Weaver M, Laske D. 2003. Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. J Neurooncol 65(1):3-13.
-
(2003)
J Neurooncol
, vol.65
, Issue.1
, pp. 3-13
-
-
Weaver, M.1
Laske, D.2
-
184
-
-
0033611472
-
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
-
Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ. 1999. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340(4):253-259.
-
(1999)
N Engl J Med
, vol.340
, Issue.4
, pp. 253-259
-
-
Weinblatt, M.E.1
Kremer, J.M.2
Bankhurst, A.D.3
Bulpitt, K.J.4
Fleischmann, R.M.5
Fox, R.I.6
Jackson, C.G.7
Lange, M.8
Burge, D.J.9
-
185
-
-
34848911993
-
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil
-
Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ. 2007. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. J Pharm Pharm Sci 10(3):350-357.
-
(2007)
J Pharm Pharm Sci
, vol.10
, Issue.3
, pp. 350-357
-
-
Wu, J.1
Lu, Y.2
Lee, A.3
Pan, X.4
Yang, X.5
Zhao, X.6
Lee, R.J.7
-
186
-
-
12644255693
-
Enhanced albumin uptake by rat tumors
-
Wunder A, Stehle G, Sinn H, Schrenk H, HoffBiederbeck D, Bader F, Friedrich E, Peschke P, MaierBorst W, Heene D. 1997. Enhanced albumin uptake by rat tumors. Int J Oncol 11(3):497-507.
-
(1997)
Int J Oncol
, vol.11
, Issue.3
, pp. 497-507
-
-
Wunder, A.1
Stehle, G.2
Sinn, H.3
Schrenk, H.4
HoffBiederbeck, D.5
Bader, F.6
Friedrich, E.7
Peschke, P.8
MaierBorst, W.9
Heene, D.10
-
187
-
-
58849142161
-
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages
-
Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng J-X, Low PS. 2009. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113(2):438-446.
-
(2009)
Blood
, vol.113
, Issue.2
, pp. 438-446
-
-
Xia, W.1
Hilgenbrink, A.R.2
Matteson, E.L.3
Lockwood, M.B.4
Cheng, J.-X.5
Low, P.S.6
-
188
-
-
80051552722
-
Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside
-
Yang F, Jin C, Jiang Y, Li J, Di Y, Ni Q, Fu D. 2011. Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside. Cancer Treat Rev 37(8):633-642.
-
(2011)
Cancer Treat Rev
, vol.37
, Issue.8
, pp. 633-642
-
-
Yang, F.1
Jin, C.2
Jiang, Y.3
Li, J.4
Di, Y.5
Ni, Q.6
Fu, D.7
-
189
-
-
34247249415
-
Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates
-
Yang J, Chen H, Vlahov IR, Cheng J-X, Low PS. 2007. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates. J Pharmacol Exp Ther 321(2):462-468.
-
(2007)
J Pharmacol Exp Ther
, vol.321
, Issue.2
, pp. 462-468
-
-
Yang, J.1
Chen, H.2
Vlahov, I.R.3
Cheng, J.-X.4
Low, P.S.5
-
190
-
-
84880182345
-
nab-Paclitaxel mechanisms of action and delivery
-
Yardley D. 2013. nab-Paclitaxel mechanisms of action and delivery. J Control Release 170(3):365-372.
-
(2013)
J Control Release
, vol.170
, Issue.3
, pp. 365-372
-
-
Yardley, D.1
-
191
-
-
0026565275
-
Design of yeast-secreted albumin derivatives for human therapy: Biological and antiviral properties of a serum albumin-CD4 genetic conjugate
-
Yeh P, Landais D, Lemaître M, Maury I, Crenne J, Becquart J, Murry-Brelier A, Boucher F, Montay G, Fleer R. 1992. Design of yeast-secreted albumin derivatives for human therapy: Biological and antiviral properties of a serum albumin-CD4 genetic conjugate. Proc Natl Acad Sci USA 89(5):1904-1908.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, Issue.5
, pp. 1904-1908
-
-
Yeh, P.1
Landais, D.2
Lemaître, M.3
Maury, I.4
Crenne, J.5
Becquart, J.6
Murry-Brelier, A.7
Boucher, F.8
Montay, G.9
Fleer, R.10
-
192
-
-
8544219695
-
Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate
-
Yoo HS, Park TG. 2004. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release 100(2):247-256.
-
(2004)
J Control Release
, vol.100
, Issue.2
, pp. 247-256
-
-
Yoo, H.S.1
Park, T.G.2
-
193
-
-
0031903379
-
Transvascular drug delivery in solid tumors
-
Yuan F. 1998. Transvascular drug delivery in solid tumors. Semin Radiat Oncol 8(3):164-175.
-
(1998)
Semin Radiat Oncol
, vol.8
, Issue.3
, pp. 164-175
-
-
Yuan, F.1
-
194
-
-
33748768760
-
Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis
-
Zaitsev S, Danielyan K, Murciano J-C, Ganguly K, Krasik T, Taylor RP, Pincus S, Jones S, Cines DB, Muzykantov VR. 2006. Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood 108(6):1895-1902.
-
(2006)
Blood
, vol.108
, Issue.6
, pp. 1895-1902
-
-
Zaitsev, S.1
Danielyan, K.2
Murciano, J.-C.3
Ganguly, K.4
Krasik, T.5
Taylor, R.P.6
Pincus, S.7
Jones, S.8
Cines, D.B.9
Muzykantov, V.R.10
-
195
-
-
77954687045
-
Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation
-
Zaitsev S, Spitzer D, Murciano JC, Ding B, Tliba S, Kowalska M, Marcos-Contreras O, Kuo A, Stepanova V, Atkinson J, Poncz M, Cines D, Muzykantov V. 2010. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation. Blood 115(25):5241-5248.
-
(2010)
Blood
, vol.115
, Issue.25
, pp. 5241-5248
-
-
Zaitsev, S.1
Spitzer, D.2
Murciano, J.C.3
Ding, B.4
Tliba, S.5
Kowalska, M.6
Marcos-Contreras, O.7
Kuo, A.8
Stepanova, V.9
Atkinson, J.10
Poncz, M.11
Cines, D.12
Muzykantov, V.13
-
196
-
-
59849093173
-
Membrane transporters and folate homeostasis: Intestinal absorption and transport into systemic compartments and tissues
-
Zhao R, Matherly LH, Goldman ID. 2009. Membrane transporters and folate homeostasis: Intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med 11:e4.
-
(2009)
Expert Rev Mol Med
, vol.11
-
-
Zhao, R.1
Matherly, L.H.2
Goldman, I.D.3
-
197
-
-
84857028902
-
Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of Parkinson's disease
-
S4:003.
-
Zhao Y, Haney M, Mahajan V, Reiner B, Dunaevsky A, Mosley R, Kabanov A, Gendelman H, Batrakova E. 2011. Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of Parkinson's disease. J Nanomed Nanotechnol S4:003.
-
(2011)
J Nanomed Nanotechnol
-
-
Zhao, Y.1
Haney, M.2
Mahajan, V.3
Reiner, B.4
Dunaevsky, A.5
Mosley, R.6
Kabanov, A.7
Gendelman, H.8
Batrakova, E.9
-
198
-
-
29144450682
-
Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents
-
Zheng G, Chen J, Li H, Glickson JD. 2005. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sci USA 102(49):17757-17762.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.49
, pp. 17757-17762
-
-
Zheng, G.1
Chen, J.2
Li, H.3
Glickson, J.D.4
-
199
-
-
77951498427
-
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7a-APTADD to breast cancer cells
-
Zheng Y, Yu B, Weecharangsan W, Piao L, Darby M, Mao Y, Koynova R, Yang X, Li H, Xu S, Lee L, Sugimoto Y, Brueggemeier R, Lee R. 2010. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7a-APTADD to breast cancer cells. Int J Pharm 390(2):234-241.
-
(2010)
Int J Pharm
, vol.390
, Issue.2
, pp. 234-241
-
-
Zheng, Y.1
Yu, B.2
Weecharangsan, W.3
Piao, L.4
Darby, M.5
Mao, Y.6
Koynova, R.7
Yang, X.8
Li, H.9
Xu, S.10
Lee, L.11
Sugimoto, Y.12
Brueggemeier, R.13
Lee, R.14
|